Key statistics
On Friday, Geron Corp (GON:DUS) closed at 3.90, -20.12% below its 52-week high of 4.89, set on Jun 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.89 |
---|---|
High | 3.96 |
Low | 3.89 |
Bid | 3.93 |
Offer | 3.99 |
Previous close | 3.96 |
Average volume | 3.18k |
---|---|
Shares outstanding | 602.80m |
Free float | 600.57m |
P/E (TTM) | -- |
Market cap | 2.56bn USD |
EPS (TTM) | -0.3595 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 18:30 GMT.
More ▼
- Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors
- Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024
- Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer
More ▼